These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Baseline pulmonary function as a predictor for survival and decline in pulmonary function over time in patients undergoing stereotactic body radiotherapy for the treatment of stage I non-small-cell lung cancer. Henderson M, McGarry R, Yiannoutsos C, Fakiris A, Hoopes D, Williams M, Timmerman R. Int J Radiat Oncol Biol Phys; 2008 Oct 01; 72(2):404-9. PubMed ID: 18394819 [Abstract] [Full Text] [Related]
3. Influence of the site of lobectomy and chronic obstructive pulmonary disease on pulmonary function: a follow-up analysis. Kushibe K, Kawaguchi T, Kimura M, Takahama M, Tojo T, Taniguchi S. Interact Cardiovasc Thorac Surg; 2009 May 01; 8(5):529-33. PubMed ID: 19201779 [Abstract] [Full Text] [Related]
4. Short-term effects of inhalative tiotropium/formoterol/budenoside versus tiotropium/formoterol in patients with newly diagnosed chronic obstructive pulmonary disease requiring surgery for lung cancer: a prospective randomized trial. Bölükbas S, Eberlein M, Eckhoff J, Schirren J. Eur J Cardiothorac Surg; 2011 Jun 01; 39(6):995-1000. PubMed ID: 20970351 [Abstract] [Full Text] [Related]
5. Lack of a dose-effect relationship for pulmonary function changes after stereotactic body radiation therapy for early-stage non-small cell lung cancer. Guckenberger M, Klement RJ, Kestin LL, Hope AJ, Belderbos J, Werner-Wasik M, Yan D, Sonke JJ, Bissonnette JP, Xiao Y, Grills IS. Int J Radiat Oncol Biol Phys; 2013 Mar 15; 85(4):1074-81. PubMed ID: 23154077 [Abstract] [Full Text] [Related]
9. Surgical treatment for lung cancer with COPD based on the Global Initiative for Chronic Obstructive Lung Disease (GOLD). Iwasaki A, Shirakusa T, Enatsu S, Maekawa S, Yoshida Y, Yoshinaga Y. Thorac Cardiovasc Surg; 2005 Jun 20; 53(3):162-7. PubMed ID: 15926096 [Abstract] [Full Text] [Related]
12. Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer - a first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study. Baumann P, Nyman J, Hoyer M, Gagliardi G, Lax I, Wennberg B, Drugge N, Ekberg L, Friesland S, Johansson KA, Lund JS, Morhed E, Nilsson K, Levin N, Paludan M, Sederholm C, Traberg A, Wittgren L, Lewensohn R. Radiother Oncol; 2008 Sep 20; 88(3):359-67. PubMed ID: 18768228 [Abstract] [Full Text] [Related]
13. Changes in pulmonary function test and cardio-pulmonary exercise capacity in COPD patients after lobar pulmonary resection. Bobbio A, Chetta A, Carbognani P, Internullo E, Verduri A, Sansebastiano G, Rusca M, Olivieri D. Eur J Cardiothorac Surg; 2005 Nov 20; 28(5):754-8. PubMed ID: 16140541 [Abstract] [Full Text] [Related]